TAG:
commercial laboratories
CPI Lab Fee Adjustment Threatened by New Bill
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…
Commercial Lab JVs With Hospitals Are Declining In Number
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: There are many reasons why a properly-designed and well-managed laboratory test joint venture (JV) between a commercial lab company and a hospital should succeed. But no matter how strong such concepts look on paper, the real world has proven to be a harsh environment. A hand…
Sigma-Aldrich, Ivax Diagnostics, i-STAT, Quest Diagnostics, Unilab
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
SIGMA-ALDRICH SELLS ITS EIA PRODUCT LINE TO IVAX DIAGNOSTICS FOLLOWING ITS DECISION TO EXIT the clinical diagnostics market, Sigma-Aldrich, Inc. has sold its global enzyme immunoassay (EIA) product line to Ivax Diagnostics, Inc., based in Miami, Florida. Th…
Is Physicians’ Office Testing Evolving Toward an Oligopoly?
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: One of the most unpopular industries with consumers is the airline industry. At the national level, it is an oligopoly—dominated by seven carriers. But in many cities, it is a monopoly, with one airline flying 80% of the seats in and out of town. Ongoing consolidation of re…
Michigan Lab Network Wins Major HMO Deal
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
CEO SUMMARY: By winning the contract for Health Alliance Plan (HAP), Joint Venture Hospital Laboratories (JVHL) captured another major exclusive managed care contract for lab testing services in Southeast Michigan. Its victory demonstrates that local hospital lab outreach programs can com…
Why Can’t Hospital Laboratories Collaborate?
By R. Lewis Dark | From the Volume IX No. 4 – March 11, 2002 Issue
MOST PEOPLE KNOWLEDGEABLE ABOUT THE INNER WORKINGS of the clinical laboratory industry generally agree that hospital laboratories possess inherent advantages over commercial laboratories—anytime a hospital lab outreach program is organized properly and marketed professionally. Certainly the manage…
New Lab Company Ready To Open In Orlando, FL
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: Within the next 60 days, a brand-new clinical laboratory company will begin operations in Orlando, Florida. In the short term, it plans to offer routine testing to physicians’ offices. However, the real goal is to create a laboratory organization with integrated information…
Lab Test Ordering On Web Presents Tough Challenges
By Robert Michel | From the Volume VIII No. 12 – September 4, 2001 Issue
CEO SUMMARY: During 1999, many factors pointed to the speedy introduction of Web-based lab test ordering between physicians’ offices and their laboratory providers. Several credible players, like Healtheon/ WebMD (now WebMD) and Advanced Health Technologies, held numerous contracts to i…
Dynacare Expands Into Chicago With Purchase of 2 Small Labs
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
IT’S A BUSINESS STRATEGY BUILT AROUND “go where they ain’t!” In recent years, Dynacare, Inc. has found its best growth comes from acquiring laboratories in areas somewhat underserved by larger national competitors. It then uses that regional base to expand outward into nearb…
Analysis of Lab Testing Market Reveals Competitive Shifts
CEO SUMMARY: Even as public lab and anatomic pathology companies enjoy sustained growth in specimen volumes and revenues, fundamental shifts in the basic marketplace have changed the competitive environment. Surprisingly, the most open market segment is anatomic pathology specimens referr…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized